Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Deloitte
Daiichi Sankyo
Citi
Healthtrust
Cipla
Dow
Colorcon
Cantor Fitzgerald
AstraZeneca

Generated: December 11, 2017

DrugPatentWatch Database Preview

ARTHROTEC Drug Profile

« Back to Dashboard

When do Arthrotec patents expire, and when can generic versions of Arthrotec launch?

Arthrotec is a drug marketed by Gd Searle Llc and is included in one NDA.

The generic ingredient in ARTHROTEC is diclofenac sodium; misoprostol. There are forty-seven drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the diclofenac sodium; misoprostol profile page.

US Patents and Regulatory Information

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-001Dec 24, 1997ABRXYesNo► Subscribe► Subscribe► Subscribe► Subscribe
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-002Dec 24, 1997ABRXYesYes► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: ARTHROTEC

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-001Dec 24, 1997► Subscribe► Subscribe
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-002Dec 24, 1997► Subscribe► Subscribe
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-002Dec 24, 1997► Subscribe► Subscribe
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-002Dec 24, 1997► Subscribe► Subscribe
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-001Dec 24, 1997► Subscribe► Subscribe
Gd Searle LlcARTHROTECdiclofenac sodium; misoprostolTABLET, DELAYED RELEASE;ORAL020607-001Dec 24, 1997► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV (Patent) Challenges for ARTHROTEC

Drugname Dosage Strength RLD Submissiondate
diclofenac sodium and misoprostolDelayed-release Tablets50 mg/0.2 mgArthrotec6/29/2009
diclofenac sodium and misoprostolDelayed-release Tablets75 mg/0.2 mgArthrotec11/28/2008

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Cipla
US Department of Justice
Argus Health
McKinsey
UBS
US Army
Julphar
Teva
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot